Working… Menu
Trial record 1 of 1 for:    NCT02937675
Previous Study | Return to List | Next Study

A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02937675
Recruitment Status : Terminated (patient recruitment)
First Posted : October 18, 2016
Last Update Posted : November 2, 2020
Information provided by (Responsible Party):
Effector Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 12, 2018
Actual Study Completion Date : April 4, 2019